Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the indolecarboxamide class, specifically an indole derivative. It is identified as an experimental agent and has been studied primarily as a potent inhibitor of coagulation factor X (F10), a serine protease involved in the blood coagulation cascade. The compound binds to factor X with high affinity (Ki ≈ 3 nM), suggesting potential anticoagulant activity. There are no approved therapeutic indications or marketed formulations for this molecule, and it remains at the research stage[6][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1-{2-[(4-chlorophenyl)amino]-2-oxoethyl}-N-(1-isopropylpiperidin-4-yl)-1H-indole-2-carboxamide.